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Abstract 
Evidence suggests that recombinant human
bone  morphogenetic  protein  2  (rhBMP-2)
increases  the  mechanical  integrity  of  callus
tissue during bone healing. This effect may be
either explained by an increase of callus for-
mation  or  a  modification  of  the  trabecular
microarchitecture.  Therefore  the  purpose  of
the study was to evaluate the potential benefit
of rhBMP-2 on the trabecular microarchitec-
ture and on multidirectional callus stiffness.
Further we asked, whether microarchitecture
changes correlate with optimized callus stiff-
ness. In this study a tibial distraction osteoge-
nesis  (DO)  model  in  12  sheep  was  used  to
determine, whether percutaneous injection of
rhBMP-2 into the distraction zone influences
the microarchitecture of the bone regenerate.
After a latency period of 4 days, the tibiae were
distracted at a rate of 1.25 mm/day over a peri-
od of 20 days, resulting in total lengthening of
25  mm.  The  operated  limbs  were  randomly
assigned to one treatment groups and one con-
trol group: (A) triple injection of rhBMP-2 (4
mg rhBMP-2/injection) and (B) no injection.
The tibiae were harvested after 74 days and
scanned by ʼCT (90 ʼm/voxel). In addition, we
conducted a multidirectional mechanical test-
ing of the tibiae by using a material testing
system to assess the multidirectional strength.
The distraction zones were tested for torsional
stiffness and bending stiffness antero-posteri-
or (AP) and medio-lateral (ML) direction, com-
pression strength and maximum axial torsion.
Statistical analysis was performed using multi-
variate analysis of variance (ANOVA) followed
by  student’s  t-test  and  Regression  analysis
using power functions with a significance level
of  P<0.05.  Triple  injections  of  rhBMP-2
induced significant changes in the trabecular
architecture of the regenerate compared with
the  control:  increased  trabecular  number
(Tb.N.) (treatment group 1.73 mm/1 vs. control
group 1.2 mm/1), increased cortical bone vol-
ume fraction (BV/TV) (treatment group 0.68
vs. control group 0.47), and decreased trabecu-
lar separation (Tb.Sp.) (treatment group 0.18
mm vs. control group 0.43 mm). 
The analyses of the mechanical strength of
regenerated  bone  showed  significant  differ-
ences  between  treatment  group  (A)  and  the
control group (B). The bending stiffness ante-
rior-posterior (treatment group 17.48 Nm vs.
control  group  8.3  Nm),  medial-lateral  (treat-
ment group 18,9 Nm vs. control group 7.92 Nm)
and  the  torsional  stiffness  (treatment  group
41.17N/° vs. control group 16.41N/°) are signif-
icantly higher in the treatment group than in
the  control  group.    The  regression  analyses
revealed  significant  non-linear  relationships
between BV/TV, TB.N., Tb.Sp. and all mechani-
cal properties. Maximal correlation coefficients
were found for the Tb.Sp. vs. the bending stiff-
ness  AP  and  ML  with  R2=0.69  and  R2=0.70
(P<0.0001). There was no significant relation
between  Connectivity  and  the  compression
strength and the maximum axial torque. This
study suggests that rhBMP-2 optimizes the tra-
becular  microarchitecture  of  the  regenerate,
which might explain the advanced mechanical
integrity of newly formed bone under rhBMP-2
treatment.
Introduction
Recombinant  human  bone  morphogenetic
protein  2  (rhBMP-2)  has  been  shown  to
enhance  bone  healing1-10 and  thereby  to
improve the mechanical integrity11,12 of bone
regenerate at a distinct time point. However, it
remains unclear whether rhBMP-2 application
just accelerates bone consolidation resulting
in  terms  of  a  time  lead  of  healing  or  even
induces a microstructural optimized trabecular
microarchitecture  in  long  bone  healing.  To
investigate this question we used a sheep dis-
traction osteogenesis (DO) model as a model
of controlled bone healing.
Specifically  we  asked,  whether  rhBMP-2
influences  the  bone  consolidation  process.
During consolidation the bone remodeling of
the callus tissue due to osteoblast and osteo-
clast activation and the mineralisation of the
bone  matrix  are  the  main  processes.  While
BMP-2  has  been  shown  to  be  a  potential
osteoinductive factor13,14 in the first instance,
it has also been shown to stimulate osteoblast
and  osteoclast  differentiation,15-20 and  to  be
involved in late stages of osteoblast develop-
ment  and  matrix  mineralisation.16,21,22
Therefore a remodeling effect during bone con-
solidation may be supposed.
Further  evidence  suggests  that  rhBMP-2
increases the mechanical integrity of the cal-
lus, but the responsible mechanism remains
unclear  since  there  are  conflicting  results
about the rhBMP-2-effect on the total amount
of callus and the callus mineralisation.1-3,6,7,11
For  trabecular  bone  the  strength  not  only
depends on the amount of calcified tissue pres-
ent, but primarily on its spatial distribution.23
Therefore the strength and the fracture resist-
ance of bone are determined by the architec-
ture of its trabecular network and its cortical
shell.24,25 However, a potential modification of
the trabecular microarchitecture by rhBMP-2
application during DO has been investigated
by Ming and Zhu et al., but these studies exam-
ined rhBMP-2 in combination with other bio-
logical agents. Other studies investigated the
effect of rhBMP-2 on bone microarchitecture
in anterior lumbar interbody fusion.26,27
In  this  study  the  microarchitecture  of  the
bone regenerate was assessed using 3D micro-
computed tomography (ʼCT). We hypothesized
that repetitive rhBMP 2-injections improve the
microarchitecture of the bone regenerate and
thereby increase its mechanical resistance. A
second hypothesis was that changes in the tra-
becular microarchitecture would correlate with
the mechanical stiffness of the callus tissue.
Materials and Methods
Animals
Twelve skeletally mature female sheep with
a mean presurgical weight of 81 kg±13.6 kg
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were used. Animals were housed indoors in
boxes during the experimentation period and
fed a standard cereal foodstuff. Animal experi-
ments were conducted under an ethic commis-
sion  approved  protocol  according  to  German
federal animal welfare legislation.
Surgery and distraction
For preanesthetic sedation animals received
5-10 mg propofol intravenous. The sheep were
intubated and fixed in a left lateral position.
Inhalation  anaesthesia  was  performed  with
Isofluran for the duration of surgery. A modi-
fied external half ring fixator,28 consisting of
four  half-rings,  connected  by  threaded  rods,
was  applied  to  the  right  tibia  under  radi-
ographic  control.  Six  5  mm  Schanz-screws
were inserted in the tibia in a defined order. A
middiaphyseal transversal osteotomy was cre-
ated over a medial approach using an oscillat-
ing saw. The periosteum was reapproximated
and the wound closed. A postoperative antimi-
crobial  prophylaxis,  consisting  of  penicillin
and  streptomycin  (0.1  mL/kg,  Tardomycel,
Bayer GmbH, Leverkusen) was applied by sub-
cutaneous injection. To protect the sheep from
hurting themselves and each other, a soft plas-
tic cover was fixed on the fixator frame.
Unrestricted  weight  bearing  and  activity
were allowed postoperatively. After a latency
period of 4 days the tibiae were distracted at a
rate of 1.25 mm daily in two increments over a
period of 20 days. The distraction resulted in
total  lengthening  of  25  mm.  The  distraction
period was followed by a consolidation period
of 50 days, during which the fixator was hold in
place  with  no  distraction.  Throughout  the
study sheep were examined daily for signs of
pin-infection and pain. Antero-posterior x-ray
views of the lengthened tibiae were performed
weekly.
Injection protocol
The operated sheep were randomly assigned
to the treatment group or the control group
resulting in 6 animals per group. Treatment
groups included: (A) triple injection of 1 mL
rhBMP-2/NaCl (4 mg rhBMP-2/ml) (Genetics
Institute, MA). The control group had no injec-
tion (B). The sheep in treatment group (A)
were injected on day 3, 10 and 17. During the
injection procedure the sheep were fixed in a
dorsal position. Injections were performed at
the center of the distraction zone (0.4 mL solu-
tion) and 1 cm distal and proximal from the
central point (0.2 mL solution each) under flu-
oroscopic control.
Sheep were then sacrificed after 74 days by
intravenous  injection  of  propofol  and  pento-
barbital (Eutha 77, Essex Pharma, Germany).
Afterwards the external fixator was removed
and the right tibiae was resected and frozen at
–20°C until ʼCT analysis were performed.
Stereological analysis
To determine 3D stereological histomorpho-
metric parameters indices a complete three-
dimensional digitized image of each distrac-
tion zone was generated using a microcomput-
ed tomography system (ʼCT). The system is
equipped with a microfocus x-ray tube with a
focal spot of 10 mm, producing a cone beam
that  is  detected  by  a  charge-couple  device
(CCD) 512ﾥ512 pixel array. The tibiae were
positioned in custom-made fixation device in
air for scanning. The whole distraction zone
with a diameter of approximately 2,5 cm was
scanned.  All  distraction  zones  were  recon-
structed on a 120 ʼm mesh, so that each 3D
data point of the reconstruction (voxel) repre-
sented a subvolume of the actual specimen of
(90ﾥ90ﾥ90 ʼm3). The distraction callus was
analyzed  for  bone  volume/total  volume
(BV/TV), trabecular number (Tb.N.: mm-1), tra-
becular  thickness  (Tb.Th.:  mm),  trabecular
separation (Tb.Sp.: mm) and Connectivity, as
defined by Parfitt and Odgaard.29;30 The region
of interest (ROI) was fit into the distraction
zone (1.) as a sphere with the diameter of the
distraction  zone:  total  volume;  (2.)  as  two
spheres with half of the diameter of the dis-
traction  zone:  cortical  weighted  subvolume
(CWS)  (Figure  1).  Both  ROI  methods  were
used to determine BV/TV. All other parameters
were measured in the cortical weighted sub-
volume (method 2). A modified algorithm of
the  Hipp  and  Simmons  method  of  directed
secants  was  used  to  compute  the  structural
parameters defined above.31
Mechanical test
Before biomechanical testing at day 74, the
frozen tibiae were thawed at room tempera-
ture  and  kept  moist  using  gauze  soaked  in
0.9% NaCl solution during the entire test peri-
od. The embedded specimens were mounted in
specially constructed jigs for compressive, 4-
point-bending,  or  torsional  testing  in  a
Material  Testing  System  (MTS  [Model  858,
MTS  Corp.,  Minneapolis,  USA])  (Figure  2).
The order of stiffness testing was randomised
and measurements were performed on each
specimen  by  using  compressive,  bending
(anteroposterior  and  mediolateral)  and  tor-
sional  stiffness.  The  resulting  deformation
was  detected  by  custom-made  compression,
torsion and deflection sensors (LVTD and pre-
cision potentiometer). For each stiffness test-
ing-procedure, a preconditioning of 10 cycles
was  conducted  before  the  actual  testing  in
order to assure repeatability. The callus tissue
within the specimens was loaded during the
different types of testing up to 15 Nm for tor-
sional, to 750 N for compressive and to 6.5 Nm
for  bending  load.  During  testing,  load  and
deformation were simultaneously recorded in
order to determine stiffness, which is defined
as the slope of the load-deformation curve. In a
final experiment, the specimens were loaded
in torsion until failure to determine the load-
bearing capacity. The detailed testing protocol
was performed as previously described.32
Statistics
The results are presented as mean and SD.
For  comparison  of  the  structural  parameters
obtained from the treatment group (A) and the
control  group  (B)  data  were  analyzed  using
multivariate analysis of variance (ANOVA) fol-
lowed  by  student’s  t-test.  The  mechanical
parameters (ordinate) and the different types of
bone  parameters  as  BV/TV,  Tb.N.  and  Tb.Sp.
were plotted in a diagram. For each measured
parameter an analysis of variance (ANOVA) was
performed  with  SPSS  Software  (SPSS,  SPSS
Inc., Chicago, USA). Regression analyses were
performed using power functions. A P value of
less than 0.05 was considered significant.
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Figure 1. Model of region of interest (ROI):
total volume and region of interest: cortical
weighted subvolume.
Figure 2. Photography of the custom-made
jig for bending testing including the spe-
cially constructed deflection sensor.[Orthopedic Reviews 2012; 4:e13] [page 61]
Results
The stereological evaluation revealed a sig-
nificantly increased higher cortical BV/TV in
the treatment group A compared the control
group  (B).  The  increase  was  given  by  45%
(P=0.001). Measured for the total volume of
the distraction zone the BV/TV showed no sig-
nificant  difference  between  the  two  groups
(Figure 3). The trabecular number (Tb.N.) in
the  treatment  group  (A)  was  significantly
increased  compared  with  the  control  group
(B).  The  percentage  difference  was  46%
(P=0.004), which corresponds to an absolute
increase  of  the  mean  trabecular  number
(Tb.N.)  by  5-6  trabeculae  per  millimeter.
Regarding  the  trabecular  spacing  (Th.Sp.),
there were significant differences between the
treatment group (A) and the control group (B).
Treatment  group  (A)  compared  with  control
group (B) had a lower mean trabecular spacing
(Tb.Sp.)  by  58%  (P=0.022),  representing  an
absolute difference of 0.25 mm. For the trabec-
ular thickness (Tb.Th.), there were no signifi-
cant differences between the treatment group
(A) and the control group (B). The maximum
trabecular  thickness  (Tb.Th.)  in  treatment
group (A) reached 0.39 mm compared to 0.35
mm in the control group (Figure 4).
The analyses of the mechanical strength of
the distraction zones indicated significant dif-
ferences  between  treatment  (A)  and  control
group  (B).  The  comparison  showed  an
increase in torsional stiffness of the treatment
group of 248% to controls (P=0.012). The ante-
rior-posterior  bending  stiffness  revealed  an
increase of 210% (P=0.007) and the medial-
lateral bending stiffness showed an increase of
239%  (P=0.002).  There  were  no  significant
differences between the treatment group and
the control group in compression and maxi-
mum axial torque (Figure 5). 
The  regression  analyses  revealed  signifi-
cant non-linear relationships between BV/TV,
Tb.N.,  Tb.Sp.  and  all  mechanical  properties.
The  Tb.Sp.  showed  the  highest  correlation
witch  each  of  the  stiffness  parameters.
Maximal  correlation  coefficients  were  found
for the Tb.Sp. vs. the bending stiffness AP and
ML  with  R2=0.69  and  R2=0.70  (P<0.0001;
n=12)  (Figure  6).  Thereby  relationship
between trabecular spacing (Tb.Sp.) and max-
imal  torsional  stiffness  was  found  to  be
inversely  proportional.  Poor  correlations  (R2
<0.4)  were  found  for  Connectivity  with  all
parameters. There was no significant correla-
tion between Connectivity and the compres-
sion strength and the maximum axial torque
(P>0.05) (Table 1).
Discussion
Our  results  indicate  that  local  rhBMP-2
application induces significant changes of the
regenerate microarchitecture in a sheep tibial
DO model. The ʼCT measurements indicated
that  the  trabecular  microstructure  of  the
rhBMP-2 treated distraction zones were char-
acterized by an increased cortical bone volume
fraction  (BV/TV),  an  increased  Tb.N  and  a
decreased  Tb.Sp.  There  were  no  significant
differences found for the Tb.Th. between the
rhBMP-2 injected group and the control. While
the  BV/TV  in  the  cortical  weighted  ROI  is
increased for treatment group (A), there were
no significant differences found for the BV/TV
in the total ROI (Figure 3). As these results
suggest, rhBMP-2 does not increase the total
amount of newly formed bone, but it enhances
the reformation of the cortex and the marrow
cavity.
These findings were confirmed by previous
studies,  which  investigated  the  effect  of
rhBMP-2 on the rate of callus formation and
mineralisation.1,5 The authors argue that the
amount of bone and cartilage in fracture cal-
lus, and therefore its size, is primarily influ-
enced by mechanical factors, while rhBMP-2
accelerates the rate of development of the cal-
lus and the cortical union. But this effect may
be time dependent. Li et al. investigated the
effect of rhBMP-2 on bone consolidation in an
rabbit DO model and found a significant high-
er bone mineral content (BMC) in the rhBMP-
2 treated groups 14 days after surgery com-
pared with the control.5 However at 28 days the
BMC  of  the  regenerate  was  similar  in  all
groups. The assimilation of the BMC between
control and treatment groups at 28 days was
explained by an advanced remodeling of the
bone  regenerate  in  the  treatment  groups,
which included a redistribution of mineralized
bone tissue from the central region of the dis-
traction zone to the newly formed cortex. Our
results have been strengthened by Zhu et al.,
who  found  an  increased  BV/TV,  Tb.Th.  and
Tb.N. and significantly decreased Tb.Sp. in the
rhBMP-2  group  compared  to  their  control
group in a rabbit model. These authors investi-
gated  the  combined  effects  of  rhBMP-2  and
NEL-like molecular-1 (NELL-1) on bone regen-
eration  in  rapid  distraction  osteogenesis.33
Moreover, they showed that the combination of
rhBMP-2  and  NELL-1  reached  the  highest
value in BV/TV, Tb.Th. and Tb.N. and the lowest
value at Th.Sp. in comparison to the control
group.  This  provides  an  indication  that  the
osteogenesis can be positively influenced by
other biological agents. Nevertheless, rhBMP-2
takes an important role, because the trabecu-
lar microarchitecture parameters were signifi-
cant higher in the rhBMP-2-only-treated group
than  in  the  NELL-1  group.  The  accelerating
effect on the cortex regeneration as found in
the current study may be explained by the fact,
that BMP is primarily expressed by chondro-
cytes during the consolidation, which are typi-
cally located in external and periosteal callus.34
A more rapid chondral ossification of the exter-
nal and periosteal callus, which is induced by
external  application  rhBMP-2,  is  likely  to
explain the enhanced cortical bone formation
in this study. Box et al. stated that rhBMP-2
does not increase the size of the callus signifi-
cantly but enhances the callus maturation so
that  the  rhBMP-2  effects  during  distraction
osteogenesis are characterized to be qualita-
tive, not quantitative.1 Some studies have been
demonstrated the potential positive influence
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Figure 3. Comparison of the bone volume
fraction (BV/TV) in the total volume and
the cortical weighted subvolume.
Figure  4.  Comparison  of  the  trabecular
number  (Tb.N),  trabecular  spacing
(Tb.Sp.) and trabecular thickness (Tb.Th.)
in the cortical weighted subvolume.[page 62] [Orthopedic Reviews 2012; 4:e13]
of rhBMP-2 on the trabecular microarchitec-
ture  of  bone,  however,  in  conjunction  with
other biological agents or other body parts. In
this study a local application of rhBMP-2 has
been shown to induce significant changes in
the callus microarchitecture. 
The microstructural changes in the cortical
subvolume: increase of Tb.N and decrease of
Tb.Sp.  are  discussed  to  be  biomechanically
highly relevant.23,35 Our results were confirmed
by Foldager et al., who investigated the differ-
ence in early osteogenesis and bone microar-
chitecture in anterior lumbar interbody fusion
with rhBMP-2, equine bone protein extract and
autograft.26 They found that BV/TV and Tb.N.
are increased in rhBMP-2 treatment group, but
Tb.Th.  significantly  decreased  as  in  osteo-
porotic  bone  morphology  after  8  weeks.
However, the connectivity density was signifi-
cantly higher in the rhBMP-2 treated group,
suggesting that the trabecular number is more
important for the bone strength than the tra-
becular thickness. 
Therefore the rhBMP-2 induced microstruc-
tural  changes,  characterized  in  the  present
study:  increased  BV/TV,  increased  Tb.N.  and
decreased Tb.Sp. correspond to the microstruc-
tural pattern formulated for a biomechanically
optimized trabecular microarchitecture. These
results coincide with the results of the current
study  as  we  found  significant  correlations
between BV/TV, Tb.N., Tb.Sp. and the mechani-
cal parameters like bending stiffness, torsional
stiffness,  compression  and  maximum  axial
torque measured by mechanical testing. These
findings were confirmed by Ni et al.who found a
higher torsional stiffness and higher maximum
torque in the investigation of rabbit DO model
with  hydroxyapatite/tri-calcium  phosphates
(HA-TCP  biomaterial),  rhBMP-2  and  alen-
dronate.36 Moreover Sandhu et al. support our
findings regarding the increased stiffness in the
treatment group when they could show that the
rhBMP-2  treated  group  had  a  significantly
increased bending stiffness in al directions com-
pared to the control group. These 3D structural
indices Tb.N and Tb.Sp were shown to have a
high ability to reflect the bone strength.37
Our assumption, that repetitive injections of
rhBMP-2  may  optimize  the  trabecular
microstructure due to an increase of Tb.N. and
decrease of Tb.Sp. resulting in an increased
bone stiffness is supported by other authors.27
In our own regression analyses we found a
strong  correlation  between  microstructure
parameters (BV/TV, Tb.N., Tb.Sp.) and the mul-
tiaxial stiffness in callus tissue. Thereby the
trabecular separation (Tb.Sp.) was observed to
be the best predictor of callus stiffness. 
On the other hand we found a poor correla-
tion between the connectivity in our 3D analy-
sis and the stiffness parameters. This observa-
tion may be explained by the presence of iso-
lated bone particles in the distraction zones,
which may be interpreted unconnected trabec-
ulae, as they have been characterized during
DO(38). Isolated particles in the 3D dataset
have been reported to produce negative values
of Connectivity.39 Thereby its obvious that iso-
lated bone particles will contribute to the bone
volume fraction of the regenerate (BV/TV) but
not to its mechanical competence.
We are aware of several limitations of our
study. First, we were unable to measure weight
bearing in the operated and limbs during con-
solidation, which may influence healing and
ultimately, the microarchitecture of the regen-
erate. Second, the microarchitecture was only
assessed in vitro at one timepoint (day 74), so
that we ware not able to evaluate the microar-
chitectural  development  during  the  healing
process. Nevertheless our data strongly sup-
port  an  effect  use  of  a  triple  injection  of
rhBMP-2 to accelerate the consolidation period
during.
In  conclusion  this  study  suggests  that  a
triple injection of rhBMP-2 optimizes the tra-
becular  microarchitecture  in  the  distraction
zone,  which  might  explain  the  advanced
mechanical  integrity  of  newly  formed  bone
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Figure 5. Comparison of the bending stiff-
ness anterior-posterior and medial-lateral,
compression, torsional stiffness and maxi-
mum axial torque.
Figure 6. Regression of trabecular separa-
tion (Tb.Sp.) vs. bending stiffness in ante-
rior-posterior  (AP)  and  medio-posterior
(ML) direction.
Table 1. Regression (R²) values of the microarchitectural parameters to the multiaxial
mechanical stiffness.
trabecular trabecular connectivity
spacing number
(Tb.Sp.) (Tb.N)
bending AP 0.69 0.53 0.31
bending ML 0.70 0.59 0.26
compression 0.53 0.35 n.sign.
torsion 0.66 0.50 0.39
max. torque 0.59 0.41 n.sign.
AP, anterior-posterior; ML, and medio-posterior [Orthopedic Reviews 2012; 4:e13] [page 63]
under  rhBMP-2  treatment  as  found  in  our
study for bending and torsional stiffness.
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